Concepedia

Publication | Open Access

A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline BRCA mutation demonstrates marked activity

DOIFull Paper Access

56

Citations

28

References

2017

Year

Jennifer K. Litton, Marion E. Scoggins, David L. Ramírez, Rashmi K. Murthy, Gary J. Whitman, Kenneth R. Hess, Beatriz E. Adrada, Stacy L. Moulder, Carlos H. Bárcenas, Vicente Valero,
npj Breast Cancer

References

YearCitations

Page 1